UA41869C2 - Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування - Google Patents

Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування

Info

Publication number
UA41869C2
UA41869C2 UA93003971A UA93003971A UA41869C2 UA 41869 C2 UA41869 C2 UA 41869C2 UA 93003971 A UA93003971 A UA 93003971A UA 93003971 A UA93003971 A UA 93003971A UA 41869 C2 UA41869 C2 UA 41869C2
Authority
UA
Ukraine
Prior art keywords
optionally substituted
group
ethanolamine
derivatives
atom
Prior art date
Application number
UA93003971A
Other languages
English (en)
Russian (ru)
Inventor
Юіті Сіокава
Юити Сиокава
Масанобу Нагано
Кійосі Танігуті
Кийоси Танигути
Казухіко Таке
Казухико ТАКЕ
Такесі Като
Такеси КАТО
Казунорі Тсубакі
Казунори Тсубаки
Original Assignee
Фудзісава Фармас'Ютікал Ко., Лтд
Фудзисава Фармасьютикал Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929202236A external-priority patent/GB9202236D0/en
Priority claimed from GB929217991A external-priority patent/GB9217991D0/en
Application filed by Фудзісава Фармас'Ютікал Ко., Лтд, Фудзисава Фармасьютикал Ко., Лтд filed Critical Фудзісава Фармас'Ютікал Ко., Лтд
Publication of UA41869C2 publication Critical patent/UA41869C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/14—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to hydrocarbon groups substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Цей винахід відноситься до нових похідних етаноламіну і їх фармакологічно прийнятних солей, які можуть бути використані як ліки. Похідні етаноламіну загальної формули (I): де R1 - фенил, нафтил, інданіл, піриділ, бензофуразаніл або бензодіоксоліл, кожний з яких може містити такі заступники, як атом галогену або гідрокси R2 - атом галогену, нітрогрупа, оксигрупа, нижча алкінільна група, необов'язково заміщена ацильною групою, нижча алкенільна група, необов'язково заміщена ацильною групою, нижча алкоксигрупа, необов'язково заміщена ацильною групою, або аміногрупа, необов'язково заміщена ацил(нижчою) алкільною групою R3 - атом водню, бензил або нижча алкільна група, необов'язково заміщена нижчою алкілтіогрупою n - ціле число від 0 до 3, а жирна лінія означає простий зв'язок або подвійний зв'язок.
UA93003971A 1992-02-03 1993-02-01 Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування UA41869C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929202236A GB9202236D0 (en) 1992-02-03 1992-02-03 New ethanolamine derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same
GB929217991A GB9217991D0 (en) 1992-08-24 1992-08-24 New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
PCT/JP1993/000113 WO1993015041A1 (en) 1992-02-03 1993-02-01 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities

Publications (1)

Publication Number Publication Date
UA41869C2 true UA41869C2 (uk) 2001-10-15

Family

ID=26300256

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93003971A UA41869C2 (uk) 1992-02-03 1993-02-01 Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування

Country Status (19)

Country Link
US (1) US5387710A (uk)
EP (1) EP0583485B1 (uk)
JP (2) JP2819435B2 (uk)
KR (1) KR100250922B1 (uk)
CN (1) CN1063430C (uk)
AT (1) ATE156804T1 (uk)
AU (1) AU666162B2 (uk)
CA (1) CA2107566A1 (uk)
DE (1) DE69313051T2 (uk)
DK (1) DK0583485T3 (uk)
ES (1) ES2105286T3 (uk)
GR (1) GR3025106T3 (uk)
HK (1) HK1000768A1 (uk)
HU (1) HU218941B (uk)
IL (1) IL104567A (uk)
MX (1) MX9300552A (uk)
TW (1) TW225513B (uk)
UA (1) UA41869C2 (uk)
WO (1) WO1993015041A1 (uk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2142453C1 (ru) * 1995-04-15 1999-12-10 Дайниппон Фармасьютикал Ко., Лтд. ПРОИЗВОДНЫЕ 1-[ω-(3,4-ДИГИДРО-2-НАФТАЛИНИЛ)АЛКИЛ]ЦИКЛИЧЕСКОГО АМИНА И СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
SG72727A1 (en) * 1996-02-19 2000-05-23 Kissei Pharmaceutical 3,4-Disubstituted phenylethanolaminotetralincarboxamide derivatives
EP0958835A4 (en) 1996-08-19 2001-04-18 Kissei Pharmaceutical THERAPEUTIC OR PREVENTIVE REMEDY AGAINST INCONTINENCE OR FREQUENT URINARY ELIMINATION
AUPO565997A0 (en) * 1997-03-17 1997-04-10 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
WO2003035600A1 (fr) * 2001-10-19 2003-05-01 Fujisawa Pharmaceutical Co., Ltd. Procede de production de derive de benzocycloheptene
US20060100195A1 (en) * 2001-11-19 2006-05-11 Takayuki Maruyama Remedies for urinary frequency
MXPA04008918A (es) * 2002-03-14 2004-11-26 Fujisawa Pharmaceutical Co Derivados de aminoalcohol como agonistas del receptor adrenergico beta-3.
ZA200503510B (en) 2002-11-07 2006-12-27 Yamanouchi Pharma Co Ltd Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
US9181187B2 (en) 2007-02-16 2015-11-10 Ono Pharmaceutical Co., Ltd. Therapeutic agent for urinary excretion disorder
WO2011112499A1 (en) * 2010-03-08 2011-09-15 Medicinova, Inc. Compositions, methods, and devices for the treatment of dysmenorrhea
EP2556049A1 (en) * 2010-04-08 2013-02-13 MediciNova, Inc. Methods and compositions for the treatment of irritable bowel syndrome
US20120309796A1 (en) * 2011-06-06 2012-12-06 Fariborz Firooznia Benzocycloheptene acetic acids
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
CN111233820B (zh) * 2018-11-29 2022-11-18 睿阜隆(杭州)生物医药有限公司 含有冠醚和二(2-甲氧基乙氧基)结构的芬戈莫德衍生物
CA3218884A1 (en) * 2021-05-11 2022-11-17 David Nutt Therapeutic aminoindane compounds and compositions
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
IT1199339B (it) * 1986-12-23 1988-12-30 Sigma Tau Ind Farmaceuti N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
EP0499755A1 (fr) * 1991-02-18 1992-08-26 MIDY S.p.A. Nouvelles phényléthanolaminotétralines, procédé pour leur préparation, intermédiaires dans ce procédé et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
JPH06506955A (ja) 1994-08-04
JP2819435B2 (ja) 1998-10-30
HUT65351A (en) 1994-05-02
ES2105286T3 (es) 1997-10-16
JP3282799B2 (ja) 2002-05-20
CN1063430C (zh) 2001-03-21
WO1993015041A1 (en) 1993-08-05
DK0583485T3 (da) 1997-10-06
HK1000768A1 (en) 1998-04-24
KR100250922B1 (ko) 2000-05-01
GR3025106T3 (en) 1998-01-30
DE69313051T2 (de) 1998-01-08
TW225513B (uk) 1994-06-21
ATE156804T1 (de) 1997-08-15
EP0583485A1 (en) 1994-02-23
AU3367993A (en) 1993-09-01
IL104567A (en) 1997-03-18
JPH1192432A (ja) 1999-04-06
US5387710A (en) 1995-02-07
IL104567A0 (en) 1993-05-13
CA2107566A1 (en) 1993-08-04
CN1084846A (zh) 1994-04-06
EP0583485B1 (en) 1997-08-13
AU666162B2 (en) 1996-02-01
HU218941B (hu) 2001-01-29
MX9300552A (es) 1993-09-01
HU9303112D0 (en) 1994-01-28
DE69313051D1 (de) 1997-09-18

Similar Documents

Publication Publication Date Title
UA41869C2 (uk) Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
CZ203295A3 (en) N-alkyl-2-substituted adenosinetriphosphate derivatives, process of their preparation and a pharmaceutical composition containing thereof
HUT38364A (en) Process for preparing new diphosphonic acid derivatives further pharmaceutical compositions containing thereof
MY109737A (en) Treatment and compounds.
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
IL127296A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
MY129540A (en) Quinazoline derivatives, pharmaceutical compositions containing them processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect
MY130233A (en) Benzanilide derivatives.
HUP0102466A2 (hu) Antiösztrogén hatású új benzo-pirán vagy tiobenzo-pirán származékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények
HUP9903459A2 (hu) Oxa- és tiabiciklo[3.1.0]hexán-karbonsavak, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
MX9803730A (es) Nuevo proceso de preparacion de derivados de fenilimidazolidina.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
EP0593766A4 (en) PYRIDONECARBOXYLIC ACID DERIVATIVE.
ES8600261A1 (es) Un compuesto fenoxi
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
TW336235B (en) 3'-aziridino-anthracycline derivatives, process for preparating them and pharmaceutical composition containing them
KR950018037A (ko) 시알산 유도체
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
ES8504190A1 (es) Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico.
NZ335325A (en) Erythromycin derivatives, method for preparing them and their use as medicine
AU5125798A (en) Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
NO973341L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
NO943826L (no) Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede